You have 9 free searches left this month | for more free features.

tumor perfusion

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Perfusion CT scan
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 6, 2022

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Liver Cancer, Tumor Recurrence, Hepatocellular Carcinoma Trial in Bologna (Hypothermic oxygenated Perfusion - HOPE)

Not yet recruiting
  • Liver Cancer
  • +4 more
  • Hypothermic oxygenated Perfusion - HOPE
  • Bologna, Italy
    IRCCS Azienda Ospedaliero-Universitaria di Bologna
May 16, 2023

Brain Tumor, Primary, Brain Tumor, Recurrent Trial in Hungary, Italy, Poland (Elucirem, Dotarem)

Recruiting
  • Brain Tumor, Primary
  • Brain Tumor, Recurrent
  • Budapest, Hungary
  • +10 more
Sep 25, 2023

Brain Tumor Adult Trial in Salt Lake City (MR Perfusion Scan, 2HG Spectroscopy Scan)

Active, not recruiting
  • Brain Tumor Adult
  • MR Perfusion Scan
  • 2HG Spectroscopy Scan
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 21, 2022

Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)

Not yet recruiting
  • Esophagus Cancer
  • +9 more
  • ActivSight
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center - Dept of Cardiothoracic
Jan 31, 2023

Brain Tumor, Brain Metastases Trial in Toronto (Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI))

Recruiting
  • Brain Tumor
  • Brain Metastases
  • Dynamic susceptibility contrast magnetic resonance imaging (DSC MRI)
  • Toronto, Ontario, Canada
    University Health Network
May 2, 2022

Brain Metastases Trial (MRI perfusion sequence)

Not yet recruiting
  • Brain Metastases
  • MRI perfusion sequence
  • (no location specified)
May 9, 2022

Cancer, Sigmoid, Cancer, Rectum Trial in Nimes (embolization of the inferior mesenteric artery, Inferior mesenteric artery

Completed
  • Cancer, Sigmoid
  • Cancer, Rectum
  • embolization of the inferior mesenteric artery
  • Inferior mesenteric artery ligation
  • Nimes, France
    CHU Nimes
Aug 3, 2021

Invasive Malignant Tumor, Metastatic Malignant Tumor in the Brain Trial in Atlanta (Dynamic Susceptibility Contrast-MRI

Recruiting
  • Invasive Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Brain
  • Dynamic Susceptibility Contrast-MRI (DSC-MRI)
  • Magnetic Resonance Imaging (MRI)
  • Atlanta, Georgia
  • +1 more
Sep 1, 2021

Liver Cirrhosis, Liver Tumor, Liver Transplant Failure and Rejection Trial in Warsaw (Hypothermic oxygenated machine perfusion,

Recruiting
  • Liver Cirrhosis
  • +2 more
  • Hypothermic oxygenated machine perfusion
  • Simple cold storage
  • Warsaw, Mazowieckie, Poland
    Department of General, Transplant and Liver Surgery, Medical Uni
Apr 12, 2021

Comparaison Between MRI Alone or Combined With Positron Emission

Recruiting
  • Brain Metastases, Adult
    • Sherbrooke, Quebec, Canada
      CIUSSS de l'Estrie-CHUS
    Oct 15, 2021

    Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Portland (drug, other, procedure,

    Terminated
    • Lung Carcinoma Metastatic in the Brain
    • Stage IV Lung Non-Small Cell Cancer AJCC v7
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 14, 2022

    Pancreatic Adenocarcinoma Resectable, Pancreatic Adenocarcinoma Locally Advanced, Pancreatic Adenocarcinoma Metastatic Trial in

    Completed
    • Pancreatic Adenocarcinoma Resectable
    • +2 more
    • Edegem, Antwerpen, Belgium
    • +1 more
    Sep 2, 2020

    Hepatocellular Carcinoma, Perfusion Scanner Trial in Amiens (Scannographic evaluation of the tumor response performed with

    Completed
    • Hepatocellular Carcinoma
    • Perfusion Scanner
    • Scannographic evaluation of the tumor response performed with mRECIST criteria after 3 months of treatment with sorafenib
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Jul 17, 2020

    CT Perfusion and Post Y-90 TARE PET/CT Dosimetry

    Withdrawn
    • Hepatocellular Carcinoma
    • CT Liver Perfusion
    • PET/CT of liver
    • Chicago, Illinois
      Rush University Medical Center
    Oct 5, 2020

    Dual-Energy CT in Head and Neck Squamous Cell Carcinomas

    Completed
    • Head and Neck Squamous Cell Carcinoma
      • Ottawa, Ontario, Canada
        The Ottawa Hospital
      Aug 4, 2020

      Perfusion and Hypoxia Evaluation in Tumors Using 18F-FDG PET/CT

      Unknown status
      • Perfusion and Hypoxia
      • 18F-FDG PET/CT initial-time imaging
      • 18F-FDG PET/CT balanced-time imaging
      • Harbin, Heil, China
        Yingying Sun
      Feb 20, 2020

      Pancreatic Ductal Adenocarcinoma Trial in Seattle (Computed Tomography Perfusion Imaging)

      Terminated
      • Pancreatic Ductal Adenocarcinoma
      • Computed Tomography Perfusion Imaging
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jun 30, 2022

      Carcinoma, Renal Cell Trial in Philadelphia (Pazopanib, DCE-MRI and Quantitative Doppler Ultrasound)

      Completed
      • Carcinoma, Renal Cell
      • Pazopanib
      • DCE-MRI and Quantitative Doppler Ultrasound
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Mar 25, 2020

      Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

      Active, not recruiting
      • Stage IA Non-Small Cell Lung Carcinoma
      • +3 more
      • Computed Tomography Perfusion Imaging
      • +2 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Aug 5, 2022

      Head and Neck Squamous Cell Carcinoma, Brain Metastases Trial in Nashville (Magnetic Resonance Imaging (MRI), Positron Emission

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • Brain Metastases
      • Magnetic Resonance Imaging (MRI)
      • +2 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Aug 10, 2023

      Tissue Perfusion, Tumor, Inflammation Trial in Leipzig (Hyperspectral imaging, Lactate acid measurement, pathological

      Unknown status
      • Tissue Perfusion
      • +3 more
      • Hyperspectral imaging
      • +2 more
      • Leipzig, Sachsen, Germany
        Universitätsklinikum Leipzig - AöR
      Sep 10, 2020

      Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules Trial in Leuven

      Unknown status
      • Patients With a Sonographically Unclassifiable Adnexal Mass Using the IOTA Simple Rules
      • Diffusion/Perfusion-weighted Magnetic Resonance Imaging
      • Leuven, Belgium
        University Hospitals Leuven
      Apr 12, 2020

      Liver Tumor, Liver Tumors Trial in Boston (N-13 ammonia or F-18 fluorodeoxyglucose, PET scan)

      Completed
      • Liver Tumor
      • Liver Neoplasms
      • N-13 ammonia or F-18 fluorodeoxyglucose
      • PET scan
      • Boston, Massachusetts
      • +1 more
      Mar 4, 2020